At Kid Risk, we focus on improving children's lives by understanding, characterizing, and communicating about the real risks that children face around the world, and on empowering policy makers, parents, kids, and others to use the best available information and analytical insights as we do our best for children. We recognize that managing risks is the key to realizing the best possible futures for everyone. Learn more about Dr. Kimberly Thompson, the Kid Risk, Inc. mission and organization, and meet our team.

Kid Risk currently focuses its research on managing the risks associated with polioviruses (read an overview) and characterizing the benefits of global investments in measles and rubella immunization. We receive funding for our research from the U.S. Centers for Disease Control and Prevention (CDC), the World Health Organization (WHO), and the Bill & Melinda Gates Foundation. Our research demonstrates that investments in public health save lives and money.

News - Dr. Kamran Badizadegan joined Kid Risk, Inc. as Vice President in October 2019. Drs. Thompson and Badizadegan co-authored a recently published article on "Modeling pathology workload and complexity to manage risks and improve patient quality and safety" published in Risk Anlaysis. The new publication highlights opportunities to use analytics to better manage anatomic pathology laboratory risks to improve quality and patient safety based on modeling applied to a large pediatric hospital.

Polio research - See coverage of our polio research in a recent article by Helen Branswell and get details about our publications related to polio.

You can also check out our other news and learn more about our research or join our mailing list to receive press releases and/or periodic updates about our work. Thank you to all of our supporters.